Erin C. Bridgeford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Erin C. Bridgeford has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Arlin B. Rogers
Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 16-825, Cambridge, Massachusetts 02139
1 shared publicationJames G. Fox
Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 16-825, Cambridge, Massachusetts 02139
1 shared publicationPrashant R. Nambiar
Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 16-825, Cambridge, Massachusetts 02139
1 shared publication
Latest Publications
- 1 May 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (5) , 1881-1884
Agammaglobulinemia and Staphylococcus aureus Botryomycosis in a Cohort of Related Sentinel Swiss Webster Mice
Sentinel mouse seroconversion to infectious agents is critical for laboratory animal facility disease monitoring. We report spontaneous emergence of non-sex-linked agammaglobulinemia with B-cell deficiency and cutaneous Staphylococcus aureus granulomatosis (botryomycosis) in a cohort of related Swiss Webster sentinel mice. Our experience reinforces the importance of immunocompetency validation in surveillance programs.
- 1 May 2008
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (5) , 1881-1884
Agammaglobulinemia and Staphylococcus aureus Botryomycosis in a Cohort of Related Sentinel Swiss Webster Mice
Sentinel mouse seroconversion to infectious agents is critical for laboratory animal facility disease monitoring. We report spontaneous emergence of non-sex-linked agammaglobulinemia with B-cell deficiency and cutaneous Staphylococcus aureus granulomatosis (botryomycosis) in a cohort of related Swiss Webster sentinel mice. Our experience reinforces the importance of immunocompetency validation in surveillance programs.